Editas Medicine (EDIT) PT Lowered to $10 at Goldman Sachs

February 24, 2022 1:07 PM EST Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Editas Medicine (EDIT) PT Lowered to $10 at Goldman Sachs

Member Login

Free News Feed